RecruitingNot ApplicableNCT06762795

The HIEnome Study: Genome Sequencing for Perinatal HIE


Sponsor

Baylor College of Medicine

Enrollment

25 participants

Start Date

May 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Perinatal hypoxic-ischemic encephalopathy is a rare severe condition in which neonates present with encephalopathy and a clinical history suggestive of prenatal or perinatal hypoxic-ischemic injury. Emerging evidence suggests that genetic conditions are frequently identified in cases of perinatal HIE; however, it is unclear which neonates with this diagnosis warrant genetic testing. This study will offer clinical genome sequencing to neonates with HIE who are undergoing total body cooling (therapeutic hypothermia) and their parents.


Eligibility

Min Age: 0 DaysMax Age: 1 Year

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Genome sequencing for people with hypoxic ischemic encephalopathy of newborn, hypoxic-ischemic encephalopathy (hie), and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 0 Days to 1 Year.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICGenome sequencing

Neonates enrolled in this study will undergo genome sequencing with parental controls as applicable.


Locations(2)

Texas Children's Hospital

Houston, Texas, United States

Texas Children's Hospital

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06762795


Related Trials